151 related articles for article (PubMed ID: 93677)
1. [Uterine hemorrhage during intrauterine contraception. Pathophysiology and therapy].
Tauber PF
Med Welt; 1979 Oct; 30(42):1547-53. PubMed ID: 93677
[No Abstract] [Full Text] [Related]
2. [Results of bleeding prevention with fibrinolysis inhibitors in intrauterine contraception].
Tauber PF; Werling E; Klöppel A; Ludwig H
Arch Gynecol; 1979 Jul; 228(1-4):637-8. PubMed ID: 485529
[No Abstract] [Full Text] [Related]
3. [Use of antifibrinolytic agents in obstetrics].
Vojta M
Cesk Gynekol; 1970 Jul; 35(6):384-6. PubMed ID: 5311001
[No Abstract] [Full Text] [Related]
4. [Contrykal as antifibrinolytic agent in obstetrics and gynecology].
Flähmig M; Sieg U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):142-50. PubMed ID: 4174652
[No Abstract] [Full Text] [Related]
5. Control of bleeding during and after prostatectomy.
Fam A
Int Surg; 1971 Nov; 56(5):352-61. PubMed ID: 5315847
[No Abstract] [Full Text] [Related]
6. [Hyperfibrinolysis].
Marx R; Matis P
Hoppe Seylers Z Physiol Chem; 1968 Jul; 349(7):934-5. PubMed ID: 5303675
[No Abstract] [Full Text] [Related]
7. [Use of epsilon aminocaproic acid in abnormal hemorrhage using intrauterine contraceptive devices].
Rueda González R
Rev Colomb Obstet Ginecol; 1969; 20(4):273-8. PubMed ID: 5356119
[TBL] [Abstract][Full Text] [Related]
8. [Defibrination syndrome in pregnancy. (Report on 7 cases at the Innsbruck University Gynecologic Clinic from 1962 to 1968)].
Kalkschmid W; Holzknecht F
Wien Med Wochenschr; 1970 Jul; 120(27):508-11. PubMed ID: 5314308
[No Abstract] [Full Text] [Related]
9. Aminocaproic acid for bleeding associated with intrauterine devices?
Drug Ther Bull; 1972 Sep; 10(20):78-80. PubMed ID: 4664710
[No Abstract] [Full Text] [Related]
10. [Indomethacin in the therapy of hemorrhage complicating intrauterine contraception].
Jánys M; Nesit V
Cesk Gynekol; 1979 May; 44(4):287-9. PubMed ID: 445610
[No Abstract] [Full Text] [Related]
11. [On the treatment of obstetrical and gynecological bleedings with a new anti-fibrinolytic agent].
Harms W
Med Welt; 1968 Mar; 10():643-51. PubMed ID: 5706212
[No Abstract] [Full Text] [Related]
12. [Studies on antiphlogistic effects of fibrinolysin inhibitors].
Feyen H; Nissen H; Rasche H; Hiemeyer V
Z Rheumaforsch; 1970; 29(9):276-86. PubMed ID: 4394179
[No Abstract] [Full Text] [Related]
13. Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.
Weström L; Bengtsson LP
J Reprod Med; 1970 Oct; 5(4):154-61. PubMed ID: 4940818
[No Abstract] [Full Text] [Related]
14. Treatment of obstetric bleeding with antifibrinolytics.
Isaksson G
Cent Afr J Med; 1973 May; 19(5):98. PubMed ID: 4541738
[No Abstract] [Full Text] [Related]
15. [Antifibrinolytic agents and their therapeutic use].
Fischer M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):64-77. PubMed ID: 4189375
[No Abstract] [Full Text] [Related]
16. [Experience with the management of gynecological bleeding using protease inhibitors].
Zvarík E
Cesk Gynekol; 1967 Aug; 32(6):426-8. PubMed ID: 5300587
[No Abstract] [Full Text] [Related]
17. The IUD and endometrial bleeding.
Rybo G
J Reprod Med; 1978 Mar; 20(3):175-82. PubMed ID: 347075
[No Abstract] [Full Text] [Related]
18. The intrauterine contraceptive device.
Barwin BN; Tuttle S; Jolly EE
Can Med Assoc J; 1978 Jan; 118(1):53-8. PubMed ID: 620385
[TBL] [Abstract][Full Text] [Related]
19. [Modern aspects of therapy in hemorrhage shock in cirrhotics].
Cairella M; Vecchi L
Clin Ter; 1966 Sep; 38(6):575-8. PubMed ID: 5300734
[No Abstract] [Full Text] [Related]
20. [Antifibrinolytic therapy in obstetrics and gynecology].
Schild W
Gynaecologia; 1965; 160(1):39-48. PubMed ID: 5294537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
